Pharmaceutical

FDA approves Selarsdi injection as interchangeable with Stelara

Teva and Alvotech have announced receipt of the US FDA approval to Selarsdi injection for use as an interchangeable with Stelara.

May 6, 2025 - 06:00
FDA approves Selarsdi injection as interchangeable with Stelara
Teva and Alvotech have announced receipt of the US FDA approval to Selarsdi injection for use as an interchangeable with Stelara.
Read the original article

Tags:

Previous Article

Swiss biotech sector’s R&D investment grew in 2024 despite global trends

Next Article

TAE Life Sciences, Ohio State University partner to advance cancer drug development

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: With new trial data, a blockbuster therapy from Sanofi, Regeneron could find an even bigger market

STAT+: With new trial data, a blockbuster therapy from ...

Nov 27, 2023

Beacon Therapeutics enters gene therapy arena with $120m launch

Beacon Therapeutics enters gene therapy arena with $120...

Jun 13, 2023

STAT+: Drug firms test medicines to halt Alzheimer’s before symptoms appear

STAT+: Drug firms test medicines to halt Alzheimer’s be...

Aug 31, 2023